Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup
January 24, 2018Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis
Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
NICE recommends for online and mobile depression programme for trial on NHS
January 24, 2018Research and Development Deprexis, NHS, NICE, app, depression, pharma
NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …
J&J withdraws controversial vaginal mesh from Australian market
January 23, 2018Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh
Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …
GSK wins case against Reckitt Benckiser over misleading ad campaign
January 23, 2018Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Nurofen, Panadol, Reckitt Benckiser, ibuprofen, paracetamol, pharma
GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …
More woes for Teva as two late-stage asthma studies bomb
January 23, 2018Manufacturing and Production, Research and Development Teva, asthma, pharma
In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
Bristol-Myers Squibb’s Yervoy scores EU approval in paediatric melanoma
January 23, 2018Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, EU, Yervoy, pharma
Bristol-Myers Squibb has revealed that its immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the …
Celgene confirms rumours, with $9bn deal for Juno
January 22, 2018Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical
It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …
The measurement underpinning government goals for UK life sciences
January 22, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma
Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …
Biogen’s Spinraza to go before NICE
January 22, 2018Sales and Marketing Biogen, Spinraza, biotech, drugs, pharma, pharmaceutical
Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …
Abcam acquires rights to over 700 Roche products in new licensing deal
January 22, 2018Sales and Marketing Abcam, Roche, partnership, pharma
Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …
Court fines Dr Reddy’s for improperly packaging products
January 22, 2018Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical
On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …
20,000 left disabled in UK due to sodium valproate use during pregnancy
January 22, 2018Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma
Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …
Sanofi finally seals big deal with $11.6bn for Bioverativ
January 22, 2018Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical
Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …
AstraZeneca scores double approvals in Japan for asthma and ovarian cancer
January 19, 2018Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma
AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …
Top Ten most popular articles on Pharmafile.com this week
January 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten
It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …
Novartis enters biosimilar agreement with Biocon
January 19, 2018Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical
Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …
Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer
January 19, 2018Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma
UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …
Gilead aims to claim edge with Pfizer CAR-T combo
January 18, 2018Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical
Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …
AstraZeneca expands drug discovery collaboration with X-Chem
January 18, 2018Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma
AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …
Riding the wave: The FDA and real world evidence
January 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence
Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
